Clinical Trial Update: Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update assessing the efficacy and safety of indacaterol in chronic obstructive pulmonary disease. Results were posted on 2011-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-08-18